Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Endophthalmitis caused by gram-negative bacteria: etiologies, antibiotic susceptibilities, and treatment outcomes.
Journal: Journal of ophthalmic inflammation and infection
Published: September 04, 2025
Reply Re: "Teprotumumab for the Treatment of Recalcitrant Thyroid Eye Disease".
Journal: Ophthalmic plastic and reconstructive surgery
Published: January 03, 2025
Multimodal imaging of dark without pressure lesions in paediatric retinal vasculitis: A cross-sectional study.
Journal: Eye (London, England)
Published: April 17, 2024
The Role of Corticosteroids and Immunomodulatory Therapy in the Management of Infectious Uveitis.
Journal: Ocular immunology and inflammation
Published: February 08, 2024
Teprotumumab for the Treatment of Recalcitrant Thyroid Eye Disease.
Journal: Ophthalmic plastic and reconstructive surgery
Published: November 16, 2023
Birdshot Chorioretinopathy in Early Adulthood: Review of Current Literature and Case Report.
Journal: International medical case reports journal
Published: August 16, 2023
Pars plana vitrectomy with internal limiting membrane flap versus pars plana vitrectomy with conventional internal limiting membrane peeling for large macular hole.
Journal: The Cochrane database of systematic reviews
Published: August 07, 2023
ASSOCIATION OF ORAL MONTELUKAST WITH REDUCED ODDS OF DEVELOPING EXUDATIVE AGE-RELATED MACULAR DEGENERATION.
Journal: Retina (Philadelphia, Pa.)
Published: June 20, 2023
Efficacy and Safety of Tocilizumab in the Management of Non-Infectious Uveitis Failed with Conventional Immunomodulatory and Anti-TNFα Therapies.
Journal: Ocular immunology and inflammation
Published: December 21, 2022
Efficacy and safety of intravitreal anti-VEGF therapy in diabetic retinopathy: what we have learned and what should we learn further?
Journal: Expert opinion on biological therapy
Published: July 12, 2022
Bilateral retinal vasculitis associated with cold agglutinin disease treated with obinutuzumab and infliximab.
Journal: American journal of ophthalmology case reports
Published: June 20, 2022
Last Updated: 09/26/2026